|
CA2432985A1
(en)
|
2001-01-23 |
2002-08-01 |
Vincent Mancuso |
Piperazine- and piperidine-derivatives as melanocortin receptor agonists
|
|
JP2004524297A
(ja)
|
2001-01-23 |
2004-08-12 |
イーライ・リリー・アンド・カンパニー |
メラノコルチン受容体アゴニスト
|
|
JP2004532838A
(ja)
|
2001-03-02 |
2004-10-28 |
ブリストル−マイヤーズ スクイブ カンパニー |
メラノコルチン受容体のモデュレーターとして有用な化合物及びそれを含む製薬組成物
|
|
US6911447B2
(en)
|
2001-04-25 |
2005-06-28 |
The Procter & Gamble Company |
Melanocortin receptor ligands
|
|
US6977264B2
(en)
|
2001-07-25 |
2005-12-20 |
Amgen Inc. |
Substituted piperidines and methods of use
|
|
US7115607B2
(en)
|
2001-07-25 |
2006-10-03 |
Amgen Inc. |
Substituted piperazinyl amides and methods of use
|
|
US7354923B2
(en)
|
2001-08-10 |
2008-04-08 |
Palatin Technologies, Inc. |
Piperazine melanocortin-specific compounds
|
|
US7456184B2
(en)
|
2003-05-01 |
2008-11-25 |
Palatin Technologies Inc. |
Melanocortin receptor-specific compounds
|
|
CA2473036A1
(en)
|
2002-01-23 |
2003-07-31 |
Paul Leslie Ornstein |
Melanocortin receptor agonists
|
|
US7026335B2
(en)
|
2002-04-30 |
2006-04-11 |
The Procter & Gamble Co. |
Melanocortin receptor ligands
|
|
US7105526B2
(en)
|
2002-06-28 |
2006-09-12 |
Banyu Pharmaceuticals Co., Ltd. |
Benzimidazole derivatives
|
|
AU2003268493A1
(en)
|
2002-09-11 |
2004-04-30 |
Merck & Co., Inc. |
Piperazine urea derivatives as melanocortin-4 receptor agonists
|
|
TW200504033A
(en)
*
|
2002-10-23 |
2005-02-01 |
Procter & Gamble |
Melanocortin receptor ligands
|
|
AU2003281978A1
(en)
*
|
2002-11-22 |
2004-06-18 |
Boehringer Ingelheim International Gmbh |
2,5-diketopiperazines for the treatment of obesity
|
|
US7772188B2
(en)
|
2003-01-28 |
2010-08-10 |
Ironwood Pharmaceuticals, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
|
WO2004078717A1
(en)
|
2003-03-03 |
2004-09-16 |
Merck & Co., Inc. |
Acylated piperazine derivatives as melanocortin-4 receptor agonists
|
|
CN100395237C
(zh)
|
2003-03-03 |
2008-06-18 |
弗·哈夫曼-拉罗切有限公司 |
用作5－ht6调节剂的2,5－取代的四氢异喹啉
|
|
EP1468999A1
(en)
*
|
2003-03-20 |
2004-10-20 |
MyoContract Ltd. |
Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators
|
|
CN1764458A
(zh)
|
2003-03-26 |
2006-04-26 |
麦克公司 |
作为黑皮质素－4受体激动剂的双环哌啶衍生物
|
|
WO2005028438A1
(ja)
|
2003-09-22 |
2005-03-31 |
Banyu Pharmaceutical Co., Ltd. |
新規ピペリジン誘導体
|
|
US20050192286A1
(en)
*
|
2003-10-22 |
2005-09-01 |
Neurocrine Biosciences, Inc. |
Ligands of melanocortin receptors and compositions and methods related thereto
|
|
WO2005042516A2
(en)
*
|
2003-10-22 |
2005-05-12 |
Neurocrine Biosciences, Inc. |
Ligands of melanocortin receptors and compositions and methods related thereto
|
|
WO2005047251A1
(en)
*
|
2003-11-12 |
2005-05-26 |
Lg Life Sciences Ltd. |
Melanocortin receptor agonists
|
|
EP1734963A4
(en)
|
2004-04-02 |
2008-06-18 |
Merck & Co Inc |
METHOD FOR TREATING PEOPLE WITH METABOLIC AND ANTHROPOMETRIC DISORDER
|
|
US7449481B2
(en)
*
|
2004-04-13 |
2008-11-11 |
Cephalon, Inc. |
Thio-substituted biaryl-methanesulfinyl derivatives
|
|
NZ562766A
(en)
|
2005-05-30 |
2011-03-31 |
Banyu Pharma Co Ltd |
Piperidine derivatives as histamine-H3 receptor antagonists
|
|
EP1916239A4
(en)
|
2005-08-10 |
2009-10-21 |
Banyu Pharma Co Ltd |
PYRIDOLVERBINDUNG
|
|
AU2006282260A1
(en)
|
2005-08-24 |
2007-03-01 |
Msd K.K. |
Phenylpyridone derivative
|
|
US20090264426A1
(en)
|
2005-09-07 |
2009-10-22 |
Shunji Sakuraba |
Bicyclic aromatic substituted pyridone derivative
|
|
US8293900B2
(en)
|
2005-09-29 |
2012-10-23 |
Merck Sharp & Dohme Corp |
Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
|
|
AU2006304305B2
(en)
|
2005-10-18 |
2010-04-01 |
Merck Sharp & Dohme Corp. |
Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
|
|
US20080255084A1
(en)
|
2005-10-21 |
2008-10-16 |
Randy Lee Webb |
Combination of Organic Compounds
|
|
EP1944301A4
(en)
|
2005-10-27 |
2012-01-04 |
Msd Kk |
NEW BENZOXATHIIN DERIVATIVES
|
|
CA2629018C
(en)
|
2005-11-10 |
2013-12-31 |
Banyu Pharmaceutical Co., Ltd. |
Aza-substituted spiro derivative
|
|
TWI332501B
(en)
*
|
2006-07-14 |
2010-11-01 |
Lg Life Sciences Ltd |
Melanocortin receptor agonists
|
|
EP2698157B1
(en)
|
2006-09-22 |
2015-05-20 |
Merck Sharp & Dohme Corp. |
Method of treatment using fatty acid synthesis inhibitors
|
|
WO2008038692A1
(en)
|
2006-09-28 |
2008-04-03 |
Banyu Pharmaceutical Co., Ltd. |
Diaryl ketimine derivative
|
|
US8106086B2
(en)
|
2007-04-02 |
2012-01-31 |
Msd K.K. |
Indoledione derivative
|
|
MX354786B
(es)
|
2007-06-04 |
2018-03-21 |
Synergy Pharmaceuticals Inc |
Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
|
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
|
EP2264026A4
(en)
|
2008-03-06 |
2012-03-28 |
Msd Kk |
ALKYLAMINOPYRIDINDERIVATE
|
|
JPWO2009119726A1
(ja)
|
2008-03-28 |
2011-07-28 |
Ｍｓｄ株式会社 |
メラニン凝集ホルモン受容体拮抗作用を有するジアリールメチルアミド誘導体
|
|
CA2726917C
(en)
|
2008-06-04 |
2018-06-26 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
|
US20110071129A1
(en)
|
2008-06-19 |
2011-03-24 |
Makoto Ando |
Spirodiamine-diaryl ketoxime derivative
|
|
US8227628B2
(en)
|
2008-07-09 |
2012-07-24 |
Northwestern University |
Method of synthesizing acetonide-protected catechol-containing compounds and intermediates produced therein
|
|
EP2321341B1
(en)
|
2008-07-16 |
2017-02-22 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
|
|
WO2010013595A1
(ja)
|
2008-07-30 |
2010-02-04 |
萬有製薬株式会社 |
５員－５員又は５員－６員縮環シクロアルキルアミン誘導体
|
|
US8410284B2
(en)
|
2008-10-22 |
2013-04-02 |
Merck Sharp & Dohme Corp |
Cyclic benzimidazole derivatives useful as anti-diabetic agents
|
|
CA2741672A1
(en)
|
2008-10-31 |
2010-05-06 |
Merck Sharp & Dohme Corp. |
Novel cyclic benzimidazole derivatives useful anti-diabetic agents
|
|
UA99555C2
(en)
|
2008-11-12 |
2012-08-27 |
Элджи Лайф Саенсез Лтд. |
Melanocortin receptor agonists
|
|
EP2358200A4
(en)
|
2008-11-17 |
2012-05-16 |
Merck Sharp & Dohme |
SUBSTITUTED BICYCLIC AMINES FOR THE TREATMENT OF DIABETES
|
|
WO2011011506A1
(en)
|
2009-07-23 |
2011-01-27 |
Schering Corporation |
Spirocyclic oxazepine compounds as stearoyl-coenzyme a delta-9 desaturase inhibitors
|
|
CA2768577A1
(en)
|
2009-07-23 |
2011-01-27 |
Schering Corporation |
Benzo-fused oxazepine compounds as stearoyl-coenzyme a delta-9 desaturase inhibitors
|
|
US9044606B2
(en)
|
2010-01-22 |
2015-06-02 |
Ethicon Endo-Surgery, Inc. |
Methods and devices for activating brown adipose tissue using electrical energy
|
|
US8476227B2
(en)
|
2010-01-22 |
2013-07-02 |
Ethicon Endo-Surgery, Inc. |
Methods of activating a melanocortin-4 receptor pathway in obese subjects
|
|
AU2011218830B2
(en)
|
2010-02-25 |
2014-07-24 |
Merck Sharp & Dohme Corp. |
Novel cyclic benzimidazole derivatives useful anti-diabetic agents
|
|
WO2011137024A1
(en)
|
2010-04-26 |
2011-11-03 |
Merck Sharp & Dohme Corp. |
Novel spiropiperidine prolylcarboxypeptidase inhibitors
|
|
EP2568812B1
(en)
|
2010-05-11 |
2016-10-26 |
Merck Sharp & Dohme Corp. |
Novel prolylcarboxypeptidase inhibitors
|
|
EP2579873A4
(en)
|
2010-06-11 |
2013-11-27 |
Merck Sharp & Dohme |
NOVEL PROLYLCARBOXYPEPTIDASE HEMMER
|
|
US9616097B2
(en)
|
2010-09-15 |
2017-04-11 |
Synergy Pharmaceuticals, Inc. |
Formulations of guanylate cyclase C agonists and methods of use
|
|
CA2826649C
(en)
|
2011-02-25 |
2016-07-26 |
Merck Sharp & Dohme Corp. |
Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents
|
|
RU2015106909A
(ru)
|
2012-08-02 |
2016-09-27 |
Мерк Шарп И Доум Корп. |
Антидиабетические трициклические соединения
|
|
BR112015019836A2
(pt)
|
2013-02-22 |
2017-07-18 |
Merck Sharp & Dohme |
composto, composição farmacêutica, e, uso de um composto
|
|
EP2970119B1
(en)
|
2013-03-14 |
2021-11-03 |
Merck Sharp & Dohme Corp. |
Novel indole derivatives useful as anti-diabetic agents
|
|
WO2014151200A2
(en)
|
2013-03-15 |
2014-09-25 |
Synergy Pharmaceuticals Inc. |
Compositions useful for the treatment of gastrointestinal disorders
|
|
JP2016514671A
(ja)
|
2013-03-15 |
2016-05-23 |
シナジー ファーマシューティカルズ インコーポレイテッド |
グアニル酸シクラーゼのアゴニストおよびその使用
|
|
CN105764916B
(zh)
|
2013-06-05 |
2021-05-18 |
博士医疗爱尔兰有限公司 |
鸟苷酸环化酶c的超纯激动剂、制备和使用所述激动剂的方法
|
|
EA030067B1
(ru)
|
2013-07-22 |
2018-06-29 |
Идорсиа Фармасьютиклз Лтд |
Производные 1-(пиперазин-1-ил)-2-([1,2,4]триазол-1-ил)этанона
|
|
WO2015051496A1
(en)
|
2013-10-08 |
2015-04-16 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
|
AR099789A1
(es)
|
2014-03-24 |
2016-08-17 |
Actelion Pharmaceuticals Ltd |
Derivados de 8-(piperazin-1-il)-1,2,3,4-tetrahidro-isoquinolina
|
|
MX389591B
(es)
|
2014-08-29 |
2025-03-20 |
Tes Pharma S R L |
INHIBIDORES DE ACIDO A-AMINO-ß-CARBOXIMUCONICO SEMIALDEHIDO DESCARBOXILASA
|
|
US10092738B2
(en)
|
2014-12-29 |
2018-10-09 |
Ethicon Llc |
Methods and devices for inhibiting nerves when activating brown adipose tissue
|
|
US10080884B2
(en)
|
2014-12-29 |
2018-09-25 |
Ethicon Llc |
Methods and devices for activating brown adipose tissue using electrical energy
|
|
AR103399A1
(es)
|
2015-01-15 |
2017-05-10 |
Actelion Pharmaceuticals Ltd |
Derivados de (r)-2-metil-piperazina como moduladores del receptor cxcr3
|
|
RS58349B1
(sr)
|
2015-01-15 |
2019-03-29 |
Idorsia Pharmaceuticals Ltd |
Hidroksialkil-piperazinski derivati kao modulatori cxcr3 receptora
|
|
MX2019004321A
(es)
|
2016-10-14 |
2019-06-12 |
Tes Pharma S R L |
Inhibidores de la acido alfa-amino-beta-carboximuconico semialdehido descarboxilasa.
|
|
US11072602B2
(en)
|
2016-12-06 |
2021-07-27 |
Merck Sharp & Dohme Corp. |
Antidiabetic heterocyclic compounds
|
|
WO2018118670A1
(en)
|
2016-12-20 |
2018-06-28 |
Merck Sharp & Dohme Corp. |
Antidiabetic spirochroman compounds
|
|
IL279152B2
(en)
*
|
2018-06-05 |
2024-09-01 |
Crinetics Pharmaceuticals Inc |
Melanocortin subtype-2 receptor antagonists and uses thereof
|
|
CN118496217A
(zh)
|
2018-11-20 |
2024-08-16 |
Tes制药有限责任公司 |
α-氨基-β-羧基己二烯二酸半醛去羧酶的抑制剂
|
|
CN118812481A
(zh)
*
|
2019-08-23 |
2024-10-22 |
持田制药株式会社 |
杂环亚基乙酰胺衍生物的制造方法
|
|
HUE068289T2
(hu)
*
|
2019-08-23 |
2024-12-28 |
Mochida Pharm Co Ltd |
Eljárás heterociklidén-acetamid származékok elõállítására
|
|
WO2021039023A1
(ja)
*
|
2019-08-23 |
2021-03-04 |
持田製薬株式会社 |
ヘテロシクリデンアセトアミド誘導体の製造方法
|
|
WO2022092910A1
(ko)
*
|
2020-10-29 |
2022-05-05 |
주식회사 엘지화학 |
멜라노코르틴 수용체 작용제 화합물의 결정형 ⅱ 및 이의 제조방법
|
|
KR102672626B1
(ko)
*
|
2020-10-29 |
2024-06-07 |
주식회사 엘지화학 |
멜라노코르틴 수용체 작용제 화합물의 결정형 ⅲ 및 이의 제조방법
|
|
JP2023548327A
(ja)
*
|
2020-10-29 |
2023-11-16 |
エルジー・ケム・リミテッド |
メラノコルチン受容体アゴニスト化合物の結晶形ｉおよびその製造方法
|
|
EP4219471A4
(en)
*
|
2020-10-29 |
2024-03-13 |
Lg Chem, Ltd. |
Amorphous melanocortin-4 receptor agonist
|
|
WO2022092914A1
(ko)
*
|
2020-10-29 |
2022-05-05 |
주식회사 엘지화학 |
멜라노코르틴 수용체 작용제 화합물의 결정형 ⅳ 및 이의 제조방법
|
|
CN116782877A
(zh)
*
|
2020-12-22 |
2023-09-19 |
株式会社Lg化学 |
作为黑皮质素-4受体的选择性激动剂的用途
|
|
US20240043407A1
(en)
*
|
2020-12-22 |
2024-02-08 |
Lg Chem, Ltd. |
Crystalline form i of melanocortin receptor agonist compound and method for preparing same
|
|
WO2022139444A1
(ko)
*
|
2020-12-22 |
2022-06-30 |
주식회사 엘지화학 |
멜라노코르틴 수용체 작용제 화합물의 결정형 ⅱ 및 이의 제조방법
|
|
US20240051919A1
(en)
*
|
2020-12-22 |
2024-02-15 |
Lg Chem, Ltd. |
Crystalline form iii of melanocortin receptor agonist compound and preparation method therefor
|
|
TWI804170B
(zh)
*
|
2021-01-21 |
2023-06-01 |
南韓商Ｌｇ化學股份有限公司 |
黑皮質素-4受體促效劑的用途
|
|
WO2022182194A1
(ko)
*
|
2021-02-26 |
2022-09-01 |
주식회사 엘지화학 |
멜라노코르틴-4 수용체 작용제
|
|
EP4317150A4
(en)
*
|
2021-05-06 |
2024-10-30 |
Lg Chem, Ltd. |
CRYSTAL FORM VII OF A MELANOCORTIN RECEPTOR AGONIST COMPOUND AND METHOD FOR THE PREPARATION THEREOF
|
|
EP4317149A4
(en)
*
|
2021-05-06 |
2024-08-21 |
Lg Chem, Ltd. |
CRYSTALLINE FORM V OF A MELANOCORTIN RECEPTOR AGONIST COMPOUND AND PROCESS FOR ITS PREPARATION
|
|
WO2022235103A1
(ko)
*
|
2021-05-07 |
2022-11-10 |
주식회사 엘지화학 |
멜라노코르틴 수용체 작용제 화합물의 황산염의 결정형 및 이의 제조방법
|
|
JP2024516739A
(ja)
*
|
2021-05-07 |
2024-04-16 |
エルジー・ケム・リミテッド |
メラノコルチン受容体アゴニスト化合物とバニリンの共結晶およびその製造方法
|
|
JP2024517271A
(ja)
*
|
2021-05-07 |
2024-04-19 |
エルジー・ケム・リミテッド |
メラノコルチン受容体アゴニスト化合物の有機酸塩の結晶形ｉｖおよびその製造方法
|